Logo image of UXIN

UXIN LTD - ADR (UXIN) Stock Fundamental Analysis

USA - NASDAQ:UXIN - US91818X3061 - ADR

3.49 USD
+0.09 (+2.65%)
Last: 10/3/2025, 8:10:05 PM
3.48 USD
-0.01 (-0.29%)
After Hours: 10/3/2025, 8:10:05 PM
Fundamental Rating

0

We assign a fundamental rating of 0 out of 10 to UXIN. UXIN was compared to 122 industry peers in the Specialty Retail industry. UXIN has a bad profitability rating. Also its financial health evaluation is rather negative. UXIN does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

UXIN had negative earnings in the past year.
In the past 5 years UXIN always reported negative net income.
In the past 5 years UXIN always reported negative operating cash flow.
UXIN Yearly Net Income VS EBIT VS OCF VS FCFUXIN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -1B -2B -3B

1.2 Ratios

UXIN has a worse Return On Assets (-15.27%) than 81.15% of its industry peers.
Industry RankSector Rank
ROA -15.27%
ROE N/A
ROIC N/A
ROA(3y)-84.07%
ROA(5y)-72.29%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
UXIN Yearly ROA, ROE, ROICUXIN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 -1K -1.5K

1.3 Margins

With a Gross Margin value of 7.02%, UXIN is not doing good in the industry: 93.44% of the companies in the same industry are doing better.
UXIN's Gross Margin has declined in the last couple of years.
UXIN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 7.02%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-36.4%
UXIN Yearly Profit, Operating, Gross MarginsUXIN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

More info and screens

0

2. Health

2.1 Basic Checks

UXIN does not have a ROIC to compare to the WACC, probably because it is not profitable.
There is no outstanding debt for UXIN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
UXIN Yearly Shares OutstandingUXIN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
UXIN Yearly Total Debt VS Total AssetsUXIN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

Based on the Altman-Z score of -12.26, we must say that UXIN is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -12.26, UXIN is doing worse than 90.98% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -12.26
ROIC/WACCN/A
WACC5.34%
UXIN Yearly LT Debt VS Equity VS FCFUXIN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B -2B

2.3 Liquidity

UXIN has a Current Ratio of 0.44. This is a bad value and indicates that UXIN is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of UXIN (0.44) is worse than 93.44% of its industry peers.
UXIN has a Quick Ratio of 0.44. This is a bad value and indicates that UXIN is not financially healthy enough and could expect problems in meeting its short term obligations.
UXIN's Quick ratio of 0.17 is on the low side compared to the rest of the industry. UXIN is outperformed by 90.16% of its industry peers.
Industry RankSector Rank
Current Ratio 0.44
Quick Ratio 0.17
UXIN Yearly Current Assets VS Current LiabilitesUXIN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

More info and screens

2

3. Growth

3.1 Past

UXIN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 100.00%, which is quite impressive.
Looking at the last year, UXIN shows a very strong growth in Revenue. The Revenue has grown by 34.91%.
The Revenue has been decreasing by -2.84% on average over the past years.
EPS 1Y (TTM)100%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)34.91%
Revenue growth 3Y27.89%
Revenue growth 5Y-2.84%
Sales Q2Q%42.47%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y33.33%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year17.05%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
UXIN Yearly Revenue VS EstimatesUXIN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B
UXIN Yearly EPS VS EstimatesUXIN Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 -20 -40 -60 -80 -100

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Forward Price/Earnings Ratio is negative for UXIN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
UXIN Price Earnings VS Forward Price EarningsUXIN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
UXIN Per share dataUXIN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for UXIN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

UXIN LTD - ADR

NASDAQ:UXIN (10/3/2025, 8:10:05 PM)

After market: 3.48 -0.01 (-0.29%)

3.49

+0.09 (+2.65%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)09-22 2025-09-22
Earnings (Next)11-24 2025-11-24
Inst Owners0.15%
Inst Owner Change-12.67%
Ins Owners0.12%
Ins Owner ChangeN/A
Market Cap719.53M
Analysts43.33
Price TargetN/A
Short Float %3.93%
Short Ratio1.22
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.33
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)-0.17
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.5
BVpS-0.25
TBVpS-0.25
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -15.27%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 7.02%
FCFM N/A
ROA(3y)-84.07%
ROA(5y)-72.29%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-36.4%
F-ScoreN/A
Asset Turnover1.12
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.44
Quick Ratio 0.17
Altman-Z -12.26
F-ScoreN/A
WACC5.34%
ROIC/WACCN/A
Cap/Depr(3y)92.95%
Cap/Depr(5y)65.68%
Cap/Sales(3y)1.23%
Cap/Sales(5y)1.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)100%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y33.33%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)34.91%
Revenue growth 3Y27.89%
Revenue growth 5Y-2.84%
Sales Q2Q%42.47%
Revenue Next Year17.05%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y22.54%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year43.39%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y3.28%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-4.32%
OCF growth 3YN/A
OCF growth 5YN/A